About Dr. Chetan Kalal — Hepatologist & Liver Transplant Physician, Mumbai
Dr. Chetan Kalal is a consultant Hepatologist and Liver Transplant Physician based in Mumbai, Maharashtra. He holds the distinction of being the first DM Hepatologist in Maharashtra — a milestone that marks a turning point in the state’s specialist liver care. He currently practises at Gleneagles Hospital, Mumbai, and has previously been affiliated with Sir H.N. Reliance Foundation Hospital and Nanavati Max Super Speciality Hospital.
Qualifications & Training
Dr. Kalal completed his DM in Hepatology from the Institute of Liver and Biliary Sciences (ILBS), New Delhi in 2016, training under the direct mentorship of Prof. Shiv Kumar Sarin — one of the world’s foremost authorities on liver disease.
Recent Academic Activity
- DRILLS 2026 — Invited Faculty (Decisions Reasoning Innovations & Learning in Liver DiseaseS, 7th Edition) — ILBS, Pullman Aerocity, New Delhi. 13–14 June 2026.
Awards & Recognition
- AASLD Foundation Young Investigator Travel Award 2016 (American Association for the Study of Liver Diseases)
- AASLD Foundation Young Investigator Travel Award 2017 (American Association for the Study of Liver Diseases)
- Fellow, National Academy of Medical Sciences — FNAMS (2022–23)
- First DM Hepatologist of Maharashtra
Clinical Expertise
- Acute-on-Chronic Liver Failure (ACLF)
- Acute Liver Failure
- Liver Transplantation (evaluation, pre- and post-transplant care)
- Viral Hepatitis — Hepatitis B, Hepatitis C, Hepatitis D
- Cirrhosis and its complications
- Alcoholic and Non-Alcoholic Fatty Liver Disease (NAFLD/MASLD)
- Drug-Induced and Herb-Induced Liver Injury (DILI/HILI)
- Portal Hypertension
- Nutrition and Sarcopenia in Liver Disease
- Endoscopy: Upper GI, Colonoscopy, Liver Biopsy, FibroScan
Research
- ACLF — contributing to APASL AARC criteria development and validation
- Acute Liver Failure — principal investigator, MAHAL (Management of Acute Hepatic fAiLure) RCT
- Nutrition and Sarcopenia in Cirrhosis
- Viral Hepatitis — epidemiology and treatment outcomes
- DILI/HILI — drug and herb-induced liver injury in the Indian population
- MASLD/Metabolic Liver Disease
Dr. Kalal has 26 publications indexed on PubMed. View his work on PubMed and Google Scholar · PubMed Profile · ORCID.
Where to Consult
Current: Gleneagles Hospital Mumbai, Maharashtra, India
Previous: Sir H.N. Reliance Foundation Hospital, Raja Rammohan Roy Rd, Prarthana Samaj, Girgaon, South Mumbai 400004 | Nanavati Max Super Speciality Hospital, Mumbai
Scholarly Identity and Research Profiles
Dr. Chetan Kalal’s research work is indexed across multiple global academic databases. Verified scholarly profiles:
- ORCID iD: https://orcid.org/0000-0002-5284-7890 — Unique researcher identifier linking all published work.
- PubMed / NCBI: PubMed author search — Kalal Chetan — 26 peer-reviewed publications indexed.
- Google Scholar: Google Scholar — Chetan Kalal Hepatology
- Frontiers Loop Profile: loop.frontiersin.org/people/1454916
International Consultations and Second Opinions
Dr. Kalal accepts teleconsultation requests and written second opinions from patients and referring physicians worldwide — including from the United Kingdom, United States, Canada, Australia, New Zealand, UAE, Gulf (GCC) countries, Singapore, East Africa, and South Africa.
NRI patients and international patients seeking expert hepatology input for liver transplant evaluation, ACLF management, chronic hepatitis, or cirrhosis are encouraged to send medical records via the contact form for a structured expert review.
Common international referrals handled by Dr. Kalal:
- Liver transplant evaluation for patients in Dubai, Abu Dhabi, and across the UAE
- Second opinion on ACLF or acute liver failure for patients in the UK and USA
- Hepatitis B and C treatment guidance for NRI patients in Canada and Australia
- Liver disease management for patients in Kenya, South Africa, and East Africa
- Pre-transplant and post-transplant follow-up teleconsultation for patients in London, New York, Toronto, and Sydney
Mumbai is a 3-hour flight from Dubai, 9 hours from London, and 10 hours from Sydney — making Gleneagles Hospital Mumbai an accessible centre for international patients requiring in-person evaluation or liver transplantation at world-class quality and a fraction of Western costs.
